Portela LVC - Search Results

1

Sepsis-induced mitochondrial dysfunction: A narrative review.

Nedel W, Deutschendorf C, Portela LVC. Nedel W, et al. Among authors: portela lvc. World J Crit Care Med. 2023 Jun 9;12(3):139-152. doi: 10.5492/wjccm.v12.i3.139. eCollection 2023 Jun 9. World J Crit Care Med. 2023. PMID: 37397587 Free PMC article. Review.

2

SHORT-TERM INFLAMMATORY BIOMARKER PROFILES ARE ASSOCIATED WITH DEFICIENT MITOCHONDRIAL BIOENERGETICS IN LYMPHOCYTES OF SEPTIC SHOCK PATIENTS-A PROSPECTIVE COHORT STUDY.

Nedel WL, Strogulski NR, Rodolphi MS, Kopczynski A, Montes THM, Portela LV. Nedel WL, et al. Shock. 2023 Feb 1;59(2):288-293. doi: 10.1097/SHK.0000000000002055. Epub 2022 Dec 8. Shock. 2023. PMID: 36795959

3

[No title available]

[No authors listed] [No authors listed] PMID: 36477648

4

Caffeine and adenosine A_2A receptors rescue neuronal development in vitro of frontal cortical neurons in a rat model of attention deficit and hyperactivity disorder.

Alves CB, Almeida AS, Marques DM, Faé AHL, Machado ACL, Oliveira DL, Portela LVC, Porciúncula LO. Alves CB, et al. Among authors: portela lvc. Neuropharmacology. 2020 Apr;166:107782. doi: 10.1016/j.neuropharm.2019.107782. Epub 2019 Nov 19. Neuropharmacology. 2020. PMID: 31756336

5

Memantine decreases neuronal degeneration in young rats submitted to LiCl-pilocarpine-induced status epilepticus.

Zenki KC, Kalinine E, Zimmer ER, Dos Santos TG, Mussulini BHM, Portela LVC, de Oliveira DL. Zenki KC, et al. Among authors: portela lvc. Neurotoxicology. 2018 May;66:45-52. doi: 10.1016/j.neuro.2018.03.005. Epub 2018 Mar 12. Neurotoxicology. 2018. PMID: 29545205 Free article.

6

Immune neutralization of the receptor for advanced glycation end products reduce liver oxidative damage induced by an acute systemic injection of lipopolysaccharide.

Tiefensee Ribeiro C, Gasparotto J, Teixeira AA, Portela LVC, Flores VNL, Moreira JCF, Gelain DP. Tiefensee Ribeiro C, et al. Among authors: portela lvc. J Biochem. 2018 Jun 1;163(6):515-523. doi: 10.1093/jb/mvy013. J Biochem. 2018. PMID: 29365096

7

Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.

Saute JA, Rieder CR, Castilhos RM, Monte TL, Schumacher-Schuh AF, Donis KC, D'Ávila R, Souza GN, Russo AD, Furtado GV, Gheno TC, Souza DO, Saraiva-Pereira ML, Portela LV, Camey S, Torman VB, Jardim LB. Saute JA, et al. J Neurol Sci. 2015 Nov 15;358(1-2):72-6. doi: 10.1016/j.jns.2015.08.019. Epub 2015 Aug 14. J Neurol Sci. 2015. PMID: 26297649 Clinical Trial.

8

Changes in Brain 14-3-3 Proteins in Response to Insulin Resistance Induced by a High Palatable Diet.

Bock H, Zimmer AR, Zimmer ER, de Souza DO, Portela LV, Saraiva-Pereira ML. Bock H, et al. Mol Neurobiol. 2015 Aug;52(1):710-8. doi: 10.1007/s12035-014-8905-4. Epub 2014 Oct 4. Mol Neurobiol. 2015. PMID: 25280668

9

A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.

Saute JA, de Castilhos RM, Monte TL, Schumacher-Schuh AF, Donis KC, D'Ávila R, Souza GN, Russo AD, Furtado GV, Gheno TC, de Souza DO, Portela LV, Saraiva-Pereira ML, Camey SA, Torman VB, de Mello Rieder CR, Jardim LB. Saute JA, et al. Mov Disord. 2014 Apr;29(4):568-73. doi: 10.1002/mds.25803. Epub 2014 Jan 7. Mov Disord. 2014. PMID: 24399647 Clinical Trial.

10

Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.

Saute JA, Silva AC, Souza GN, Russo AD, Donis KC, Vedolin L, Saraiva-Pereira ML, Portela LV, Jardim LB. Saute JA, et al. Cerebellum. 2012 Sep;11(3):771-4. doi: 10.1007/s12311-011-0326-6. Cerebellum. 2012. PMID: 22090366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page